238 per cent returns in this high ROE & high ROCE multibagger stock: Board announces 1:1 bonus shares!

The shares of the company have a ROE of 53.2 per cent and a ROCE of 36.7 per cent.

Infinium Pharmachem Ltd informed that the meeting of the Board of Directors of the company is scheduled to be held on Thursday, September 14, 2023, at the Registered Office of the company to consider, inter alia, the following items:

1. To take note of the minutes of previous Board and Committee meetings.
2. To take note of In-principal approval for the bonus issue received from the NSE.
3. To take note of the Increase in Authorized share capital of the company.
4. To approve the allotment of 69,58,060 bonus equity shares of Rs 10 each, in the proportion of 1 (One) bonus share for every 1 (One) equity share held as of the record date of Wednesday, September 13, 2023.
5. Any other agenda with the permission of the Chair.

Infinium Pharmachem Limited manufactures & supplies Iodine derivatives, APIs, and Iodination reaction-based bulk drugs. The company has a market cap of Rs 348 crore. According to the annual results, the net sales increased by 15.15 per cent to Rs 114 crore and net profit increased by 42.86 per cent to Rs 10 crore in FY23 over FY22.

On Wednesday, shares of Infinium Pharmachem Ltd were locked in a 5 per cent lower circuit to Rs 500.55 per share from its previous closing of Rs 526.90 per share. The stock is an SME stock with a lot size of 1,000 shares.

The shares of the company have a ROE of 53.2 per cent and a ROCE of 36.7 per cent. The stock gave multibagger returns of 238 per cent in just 6 months. Investors should keep an eye on this stock.

Disclaimer: The article is for informational purposes only and not investment advice.